Literature DB >> 28755025

Inflammatory Bowel Disease in Primary Immunodeficiencies.

Judith R Kelsen1, Kathleen E Sullivan2.   

Abstract

PURPOSE OF REVIEW: Inflammatory bowel disease is most often a polygenic disorder with contributions from the intestinal microbiome, defects in barrier function, and dysregulated host responses to microbial stimulation. There is, however, increasing recognition of single gene defects that underlie a subset of patients with inflammatory bowel disease, particularly those with early-onset disease, and this review focuses on the primary immunodeficiencies associated with early-onset inflammatory bowel disease. RECENT
FINDINGS: The advent of next-generation sequencing has led to an improved recognition of single gene defects underlying some cases of inflammatory bowel disease. Among single gene defects, immune response genes are the most frequent category identified. This is also true of common genetic variants associated with inflammatory bowel disease, supporting a pivotal role for host responses in the pathogenesis. This review focuses on practical aspects related to diagnosis and management of children with inflammatory bowel disease who have underlying primary immunodeficiencies.

Entities:  

Keywords:  Crohn’s colitis; Early-onset IBD; Monogenic IBD; Ulcerative colitis

Mesh:

Year:  2017        PMID: 28755025      PMCID: PMC6953999          DOI: 10.1007/s11882-017-0724-z

Source DB:  PubMed          Journal:  Curr Allergy Asthma Rep        ISSN: 1529-7322            Impact factor:   4.806


  44 in total

1.  Clinical epidemiology of inflammatory bowel disease: Incidence, prevalence, and environmental influences.

Authors:  Edward V Loftus
Journal:  Gastroenterology       Date:  2004-05       Impact factor: 22.682

2.  Intestinal disease in Hermansky-Pudlak syndrome: occurrence of colitis and relation to genotype.

Authors:  Nadeem Hussain; Martha Quezado; Marjan Huizing; David Geho; James G White; William Gahl; Peter Mannon
Journal:  Clin Gastroenterol Hepatol       Date:  2006-01       Impact factor: 11.382

3.  Gastrointestinal histopathology in chronic granulomatous disease: a study of 87 patients.

Authors:  Meghna Alimchandani; Jin-Ping Lai; Phyu Phyu Aung; Sajneet Khangura; Natasha Kamal; John I Gallin; Steven M Holland; Harry L Malech; Theo Heller; Markku Miettinen; Martha M Quezado
Journal:  Am J Surg Pathol       Date:  2013-09       Impact factor: 6.394

4.  Inflammatory bowel disease: the difference between children and adults.

Authors:  Judith Kelsen; Robert N Baldassano
Journal:  Inflamm Bowel Dis       Date:  2008-10       Impact factor: 5.325

Review 5.  Diet therapy for inflammatory bowel diseases: The established and the new.

Authors:  Franziska Durchschein; Wolfgang Petritsch; Heinz F Hammer
Journal:  World J Gastroenterol       Date:  2016-02-21       Impact factor: 5.742

6.  Predictors of response to Infliximab in children with luminal Crohn's disease.

Authors:  Zubin Grover; Rebecca Biron; Nicholas Carman; Peter Lewindon
Journal:  J Crohns Colitis       Date:  2014-01-18       Impact factor: 9.071

7.  Clinical outcome of ulcerative colitis in children.

Authors:  J S Hyams; P Davis; K Grancher; T Lerer; C J Justinich; J Markowitz
Journal:  J Pediatr       Date:  1996-07       Impact factor: 4.406

8.  Exome sequencing analysis reveals variants in primary immunodeficiency genes in patients with very early onset inflammatory bowel disease.

Authors:  Judith R Kelsen; Noor Dawany; Christopher J Moran; Britt-Sabina Petersen; Mahdi Sarmady; Ariella Sasson; Helen Pauly-Hubbard; Alejandro Martinez; Kelly Maurer; Joanne Soong; Eric Rappaport; Andre Franke; Andreas Keller; Harland S Winter; Petar Mamula; David Piccoli; David Artis; Gregory F Sonnenberg; Mark Daly; Kathleen E Sullivan; Robert N Baldassano; Marcella Devoto
Journal:  Gastroenterology       Date:  2015-07-17       Impact factor: 22.682

9.  CD68 expression is markedly different in Crohn's disease and the colitis associated with chronic granulomatous disease.

Authors:  Steven Liu; Pierre A Russo; Robert N Baldassano; Kathleen E Sullivan
Journal:  Inflamm Bowel Dis       Date:  2009-08       Impact factor: 5.325

10.  Association between insertion mutation in NOD2 gene and Crohn's disease in German and British populations.

Authors:  J Hampe; A Cuthbert; P J Croucher; M M Mirza; S Mascheretti; S Fisher; H Frenzel; K King; A Hasselmeyer; A J MacPherson; S Bridger; S van Deventer; A Forbes; S Nikolaus; J E Lennard-Jones; U R Foelsch; M Krawczak; C Lewis; S Schreiber; C G Mathew
Journal:  Lancet       Date:  2001-06-16       Impact factor: 79.321

View more
  8 in total

Review 1.  Beyond Infections: New Warning Signs for Inborn Errors of Immunity in Children.

Authors:  Giorgio Costagliola; Diego G Peroni; Rita Consolini
Journal:  Front Pediatr       Date:  2022-06-10       Impact factor: 3.569

2.  Clinical Characteristics, In Silico Analysis, and Intervention of Neonatal-Onset Inflammatory Bowel Disease With Combined Immunodeficiency Caused by Novel TTC7A Variants.

Authors:  Yun-E Chen; Jingfang Chen; Wenxing Guo; Yanhong Zhang; Jialing Li; Hui Xie; Tong Shen; Yunsheng Ge; Yanru Huang; Wenying Zheng; Mei Lu
Journal:  Front Genet       Date:  2022-06-16       Impact factor: 4.772

3.  The immunologic features of patients with early-onset and polyautoimmunity.

Authors:  Kacie J Hoyt; Talal A Chatila; Luigi D Notarangelo; Melissa M Hazen; Erin Janssen; Lauren A Henderson
Journal:  Clin Immunol       Date:  2019-12-12       Impact factor: 3.969

Review 4.  Very early-onset inflammatory bowel disease: an integrated approach.

Authors:  Kathleen E Sullivan; Maire Conrad; Judith R Kelsen
Journal:  Curr Opin Allergy Clin Immunol       Date:  2018-12

5.  Gene analysis of seven cases of primary immunodeficiency.

Authors:  Ying Zhu; Li Li; Guoshun Mao; Lei Zhang; Jing Wang; Nannan Li
Journal:  Transl Pediatr       Date:  2020-04

Review 6.  The Role of Autophagy in Inflammatory Bowel Disease.

Authors:  Bo-Zong Shao; Yi Yao; Jun-Shan Zhai; Jian-Hua Zhu; Jin-Ping Li; Kai Wu
Journal:  Front Physiol       Date:  2021-02-03       Impact factor: 4.566

7.  Machine learning gene expression predicting model for ustekinumab response in patients with Crohn's disease.

Authors:  Manrong He; Chao Li; Wanxin Tang; Yingxi Kang; Yongdi Zuo; Yufang Wang
Journal:  Immun Inflamm Dis       Date:  2021-09-01

8.  Dioscin ameliorates inflammatory bowel disease by up-regulating miR-125a-5p to regulate macrophage polarization.

Authors:  Lingyan Shi; Peichen Zhang; Ruifang Jin; Xiaowei Chen; Lemei Dong; Weichang Chen
Journal:  J Clin Lab Anal       Date:  2022-05-07       Impact factor: 3.124

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.